Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals visits New to the Street

Apr 20, 2021

Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals talks about their pipeline of drugs in development – the Rally Study for Fibromyalgia confirmatory phase 3 study, their recent 10K, their recent raise of 110M gross funds raised in 2021, and the TNX 1800 Covid vaccine

#crypto #cryptocurrency #financialnews #newtothestreet #exploringtheblock #blockchain #blockchainnews #digitalcurrency #businessnews #tonixpharmaceuticals

Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals visits New to the Street

Recommended

FreeCast CEO Explains the Platform Unifying Streaming, Telecom and Global Media

FreeCast Targets New Global Media Opportunity for Telecom and Connectivity Providers

Roadzen Posts 49% Revenue Growth, Outpacing Broadcom and Figma

Acurx CEO: FDA Opens Potential Faster Path for New C. Diff Antibiotic

Safe Space Global CEO Unveils AI System Designed to Detect Concealed Weapons at Schools

Safe Space Global CFO: Company Reaches Inflection Point as Security Business Prepares to Scale

Seth Lederman, M.D., Chief Executive Officer of Tonix Pharmaceuticals visits New to the Street

Recommended

FreeCast CEO Explains the Platform Unifying Streaming, Telecom and Global Media

FreeCast Targets New Global Media Opportunity for Telecom and Connectivity Providers

Roadzen Posts 49% Revenue Growth, Outpacing Broadcom and Figma

Acurx CEO: FDA Opens Potential Faster Path for New C. Diff Antibiotic

Safe Space Global CEO Unveils AI System Designed to Detect Concealed Weapons at Schools

Safe Space Global CFO: Company Reaches Inflection Point as Security Business Prepares to Scale

Share

Investor Accreditation

For Individuals

Thank You!